Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

<p>Abstract</p> <p>Background</p> <p>Donepezil 23 mg/d, recently approved in the United States for treatment of moderate to severe Alzheimer's disease (AD), was developed to address the need for an additional treatment option for patients with advanced AD. This rep...

Full description

Bibliographic Details
Main Authors: Zou Heng, Bibbiani Francesco, Brand-Schieber Elimor, Yardley Jane, Moline Margaret, Veloso Felix, Farlow Martin, Hsu Timothy, Satlin Andrew
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/11/57

Similar Items

Similar Items